Abstract
This cross-sectional study examines glucagon-like peptide-1 (GLP-1) receptor agonist initiation rates among postpartum women with commercial insurance in the US.
Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureSih-Ting Cai, Kosali Simon, Anthony L. Shanks, Coady Wing
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
15. Management of diabetes in pregnancy: standards of care in diabetes-2024.
10.2337/dc24-s015 · 2024
Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis.
10.1136/bmj.m1361 · 2020
Postpartum weight retention risk factors and relationship to obesity at 1 year.
10.1097/aog.0000000000000565 · 2015
Preexisting diabetes and pregnancy: an Endocrine Society and European Society of Endocrinology joint clinical practice guideline.
10.1093/ejendo/lvaf116 · 2025
Increasing postpartum use of GLP-1 receptor agonists.
10.1001/jama.2025.20947 · 2025
Identification of pregnancies and their outcomes in healthcare claims data, 2008-2019: an algorithm.
10.1371/journal.pone.0284893 · 2023
Validation of body mass index (BMI)-related ICD-9-CM and ICD-10-CM administrative diagnosis codes recorded in US claims data.
10.1002/pds.4617 · 2018
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
Unresolved referenced work
Kept as external metadata until matched
No additional external references are available.